Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer

Register of interests DG34 original guidance development (PDF 301 KB)

Equality impact assessment DG34 original guidance development (PDF 196 KB)

Register of interests (PDF 550 KB)

Stakeholder comments on the draft guidance and responses (PDF 1.35 MB)

Additional scenario analyses (PDF 263 KB)

Diagnostics consultation: 1

Draft guidance (PDF version) (PDF 223 KB)

Diagnostics consultation document (Online commenting)

Committee papers (PDF 7.62 MB)

Equality impact assessment (PDF 130 KB)

Stakeholder list (PDF 115 KB)

Final scope (PDF 384 KB)

Final protocol (PDF 544 KB)

NICE’s response to comments on draft scope (PDF 480 KB)

Final protocol DG34 original guidance development (PDF 782 KB)

Final scope DG34 original guidance development (PDF 459 KB)

Equality impact assessment DG34 original guidance development (PDF 229 KB)

Specialist committee members DG34 original guidance development (PDF 172 KB)

Stakeholder list DG34 original guidance development (PDF 180 KB)

Draft scope consultation

Draft scope (pdf version) (PDF 407 KB)

Stakeholder matrix (PDF 129 KB)

Comments form (MSWord 28 KB)

Topic description (MSWord 26 KB)

Second consultation comments and responses DG34 original guidance development (PDF 3.69 MB)

Consultation comments and responses DG34 original guidance development (PDF 2.7 MB)

Diagnostics assessment report DG34 original guidance development (PDF 10.32 MB)

DAR addenda, errata, stakeholder comments and responses DG34 original guidance development (PDF 7.82 MB)